D'AVANZO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.201
EU - Europa 197
AS - Asia 143
OC - Oceania 2
Totale 1.543
Nazione #
US - Stati Uniti d'America 1.199
CN - Cina 81
SE - Svezia 55
SG - Singapore 53
IT - Italia 42
DE - Germania 22
FI - Finlandia 21
GB - Regno Unito 17
FR - Francia 13
UA - Ucraina 11
IE - Irlanda 9
IN - India 5
RU - Federazione Russa 3
AU - Australia 2
BD - Bangladesh 1
ES - Italia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
JP - Giappone 1
MX - Messico 1
NL - Olanda 1
PA - Panama 1
PT - Portogallo 1
Totale 1.543
Città #
Fairfield 168
Houston 133
Ann Arbor 109
Woodbridge 109
Chandler 99
Ashburn 82
Cambridge 74
Wilmington 70
Seattle 57
Singapore 39
Boardman 28
Santa Clara 28
Jacksonville 24
Des Moines 22
Padova 20
Medford 17
New York 17
Princeton 17
San Diego 17
Beijing 14
Munich 10
Dublin 9
Helsinki 9
Nanjing 7
Cagliari 6
Falls Church 4
Auburn Hills 3
Shanghai 3
Changsha 2
Handan 2
Huzhou 2
Kharkiv 2
Lanzhou 2
Milan 2
Mumbai 2
Nanchang 2
Neustadt am Ruebenberge 2
Paris 2
Phoenix 2
Vicenza 2
Changzhou 1
Chongqing 1
Dallas 1
Frankfurt am Main 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Hefei 1
Hengshui 1
Hong Kong 1
Indiana 1
Jakarta 1
Jianning 1
Jinhua 1
Kilburn 1
La Barca 1
Lappeenranta 1
London 1
Los Angeles 1
Melbourne 1
Monza 1
Nanyang 1
Norwalk 1
Novoli 1
Nuremberg 1
Panama City 1
Perris 1
Rockville 1
Rome 1
San Jose 1
Sant'elena 1
Shenyang 1
Sydney 1
Tappahannock 1
Teaneck 1
Tianjin 1
Tokyo 1
Treviso 1
Xi'an 1
Zhengzhou 1
Totale 1.259
Nome #
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment 155
QueryOR: a comprehensive web platform for genetic variant analysis and prioritization 148
RNA-seq Transcriptome Profiling Of Primary Hunter Cells Following Treatment With Recombinant IDS As A First Step For Identification Of ERT Efficacy Markers 138
Glial degeneration with oxidative damage drives neuronal demise in MPSII disease 117
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders 116
Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model 113
Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved 105
Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years 87
BBB Crossing in Lysosomal Storage Disorders: A Nanoparticle-Based Approach 82
Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases. 73
The ethical framework for performing research with rare inherited neurometabolic disease patients 72
Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders Inherited metabolic diseases 71
Targeting brain disease in MPSII: Preclinical evaluation of IDS-loaded PLGA nanoparticles 71
Analysis of Hunter Syndrome by RNA-Sequencing 66
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study 52
Setup and Validation of a Targeted Next-Generation Sequencing Approach for the Diagnosis of Lysosomal Storage Disorders 48
Mucopolysaccharidosis type II: One hundred years of research, diagnosis, and treatment 34
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy 24
Totale 1.572
Categoria #
all - tutte 6.696
article - articoli 6.372
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020137 0 0 0 0 0 0 21 32 24 28 24 8
2020/2021233 12 8 4 7 13 12 6 16 29 105 12 9
2021/2022280 16 21 20 29 41 20 15 25 24 7 17 45
2022/2023209 27 15 5 30 30 40 3 14 26 5 11 3
2023/2024127 4 19 10 12 9 27 12 7 0 3 15 9
2024/2025162 3 17 34 26 55 24 3 0 0 0 0 0
Totale 1.572